Acute Coronary Syndrome Manifesting as an Adverse Effect of All-trans-Retinoic Acid in Acute Promyelocytic Leukemia: A Case Report with Review of the Literature and a Spotlight on Management.

A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83

All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med (1997) 4.79

The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med (1992) 2.99

Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood (1998) 1.90

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood (2008) 1.57

Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood (2000) 1.41

The QT interval and torsade de pointes. Drug Saf (1999) 1.39

Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia (2006) 1.38

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol (2001) 1.09

Treatment of acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program (2006) 1.07

Retinoic acid syndrome. Recognition, prevention and management. Drug Saf (1998) 0.96

All-trans retinoic acid in acute promyelocytic leukaemia. Best Pract Res Clin Haematol (2003) 0.94

Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: a single center experience. Am J Hematol (2002) 0.90

Disseminated intravascular coagulation in the aged complicated by acute myocardial infarction. Jpn J Med (1981) 0.89

A clinicopathological study on cardiac lesions in 64 cases of disseminated intravascular coagulation. Jpn Heart J (1977) 0.84

Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia (1993) 0.83

Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood (1985) 0.83

Cardiac stunning as a manifestation of ATRA differentiation syndrome in acute promyelocytic leukemia. Med Oncol (2011) 0.83

Protein C decreases in experimental DIC in rats. Thromb Res (1990) 0.81

[Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid]. Rinsho Ketsueki (2002) 0.81

Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters. Thromb Haemost (1985) 0.81

High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol (2003) 0.80

The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 years. Ann Oncol (1997) 0.78

Elevated fibrinogen causes thrombosis. Blood (2011) 0.78